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The International Federation of Kidney Foundations surveyed
its members on chronic kidney disease ‘prevention’ programs
in their regions and countries in 2005 and 2007. A profile was
developed, representing 28 countries (56% response). Some
form of screening activity was reported in 24 of the 28
countries (85.7%). Two countries (7%) had, or anticipated
development of, legislated national screening. Programs were
conducted by kidney foundations or research groups, and
were variously population based, focused on high risk groups
or opportunistic. Tests in 63% of responding programs
included weight, height, blood pressure, blood glucose,
dipstick urinalysis and serum creatinine. Several programs
used the USA’s Kidney Early Evaluation Program’s and
International Society of Nephrology’s templates. World
Kidney Day activities contributed significantly. Stated needs
were for more government recognition, firm policies and
approaches, and critically, resources. Repeat responders
reported progress in 2007, particularly in government
interest and education delivery. Despite difficulties, programs
are developing in many regions. Most need more resources
and some members need substantial and sustained
assistance.
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A few years ago, the International Federation of Kidney
Foundations (IFKF) expanded its focus to include
prevention of chronic kidney disease (CKD) and its
detection and management. This report summarizes the
status of such programs among IFKF member organizations
and regions who answered questionnaires in 2005 and
2007.
RESULTS
A total of 50 countries and 69 organizations were surveyed. A
total of 36 questionnaires and two letters/summaries were
returned from 28 countries (56% response) and 34
organizations (49% response). These constitute the baseline
profiles described.
Countries and regions
Table 1 shows the organizations who responded, the country
and the year of the responses.
Programs reported
Argentina. Asociacion Solidaria de Insuficientes Renales
conducts education and information programs and sporadic
screenings of high-risk groups in local areas during educa-
tional congresses.
Australia. Kidney Health Australia has appointed a
national task force and developed a national chronic kidney
disease strategy. It has compiled a national education
program, focused on general practitioners but distributed
to all health professionals nationwide, a book on Manage-
ment of CKD in General Practice, and developed an accredited
practice nurse program. It is also piloting a CKD detection
program in 3–4 communities, and has supported the
population-based Aboriginal Chronic Disease Outreach
Program in six remote health services. It endorses the
National Aboriginal Community Controlled Health Organi-
zation’s National Guide to a Preventative Health Assessment in
Aboriginal & Torres Strait Islander Peoples, and the Indigen-
ous chronic disease programs supported by Australian
government agencies.
Bangladesh. There are local population-based rural and
urban programs in Dhaka for screening of diabetes,
hypertension, and proteinuria.
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Bulgaria. Bulgaria Renal Association began a CKD
screening program of high-risk groups in 2007.
Canada. Czech Kidney Foundation conducts hyperten-
sion and glucose checks at community locations. British
Columbia has a CKD screening initiative. The Canadian
Society of Nephrology has developed guidelines for health
professionals and educational tools. There is e-GFR reporting
in Ontario, British Columbia, and Alberta. The Public Policy
Council is investigating the feasibility of a national-targeted
screening program.
Czech Republic. Czech Kidney Foundation and the Czech
Society of Nephrology are preparing a registry of patients
with CKD stage 4, and will consider extension to earlier
stages of CKD, especially in high-risk groups. There is
chronic disease screening in some outpatient nephrology
services.
Egypt. No regular screening or education programs were
reported in 2005.
Fiji. Education of high-risk groups is occurring. Limited
screening is conducted as part of diabetes evaluations.
India. National Kidney Foundation India has rural
detection and prevention programs in Chennai and Mysore
and has started new education campaigns amongst school
children. It also supports the Screening Education Evaluation
Kidney Program in Mumbai (2005)—involving 21 centers
and 53 community camps at last report. The Tamilnadu
Kidney Research Foundation reports improved CKD
awareness, is attracting additional sponsors, and has devel-
oped an important CKD publication. It also has new
localized regular screening programs for company and bank
employees and clubs, and camps to serve people in rural areas
in Tamilnadu. Institute of Nova Kidney Foundation in
Kerala, with other foundations, nongovernmental organiza-
tions, and government, has initiated diabetes and hyperten-
sion screening in rural and urban areas in all states, targeting
adults.
Iran. No regular screening or education programs were
reported in 2007.
Ireland. A plan for a national strategy was reported in
2005. It had established within the Health Services’ executive
a multidisciplinary professional and advocacy National Renal
Strategy review group, which would develop a national plan
to screen high-risk groups over the next year.
Italy. Fondazione Italiana del Rene has a mobile national
screening program for high-risk groups, conducted from
trucks and gazebos in city squares or main streets. It had
reached 71 cities at the time of reporting.
Japan. Japan has had a legislated population-based CKD
screening program since the 1970s, which has included
school children and company workers, and since 1983, adults
X40 years. They are offered periodic health checks which
include urinalysis, and since 1992, serum creatinine. Inter-
national Kidney Evaluation Association Japan commenced a
version of the USA’s National Kidney Foundation (NKF)
Kidney Early Evaluation Program (KEEP) in 2006, screening
high-risk groups.
Malaysia. Kidney Foundation Malaysia has established a
nationwide screening campaign at the 20 Kidney Foundation
Malaysia centers, targeting the general population. Screening
for high-risk groups is based in hospitals.
Mexico. In 2005, screening of individuals was within
diabetes programs only. Fundacion Mexicana del Rinon is to
start a version of KEEP in 2008.
Moldova. A screening template was adapted from the
International Society of Nephrology’s (ISN’s) prevention
program, with people screened in the general practitioner
setting.
New Zealand. Local screening of high-risk groups is
encouraged, linked with screening for, and management of,
diabetes.
Nigeria. In. 2005, Kidney Watch Initiative reported
multiple educational initiatives in many cities. Kidney
Consultants International reported that there were no
sustainable nationwide screening programs but there was
improved CKD awareness and follow-up and referral of
patients (2007).
Table 1 | Responding IFKF member organizations, country
and response year(s)
Asociacion Solidaria de Insuficientes Renales (ASIR), Argentina 2007
Kidney Health Australia (KHA), Australia 2005/2007
Aboriginal Chronic Disease Outreach Program (ACDOP), Australia 2005
Kidney Foundation (KF), Bangladesh 2007
Bulgaria Renal Association (BRA), Bulgaria 2007
Kidney Foundation of Canada (KFC), Canada 2005/2007
Czech Kidney Foundation (CKF), Czech Republic 2007
National Kidney Foundation Egypt (NKFE), Egypt 2005
Kidney Foundation of Fiji (KFF), The Republic of the Fiji Islands 2005
National Kidney Foundation India (NKFI), India 2005/2007
Tamilnadu Kidney Research Foundation (TANKER), India 2005/2007
Institute of Nova Kidney Foundation (INKF), India 2007
Patient’s Kidney Foundation of Iran (PKFI), Iran 2007
Irish Kidney Association (IKA), Ireland 2005
Fondazione Italiana del Rene (FIR), Italy 2007
Renal Child Foundation (RCF), Italy 2007
International Kidney Evaluation Association Japan (IKEAJ), Japan 2007
Kidney Foundation Malaysia (KFM), Malaysia 2005/2007
Fundacion Mexicana del Rinon (FMR), Mexico 2005/2007
Kidney Foundation of Moldova (KFM), Moldova 2007
New Zealand Kidney Foundation (NZKF), New Zealand 2007
Kidney Watch Initiative (KWI), Nigeria 2005
Kidney Consultants International (KCI), Nigeria 2007
Kidney Foundation of Pakistan (KFP), Pakistan 2007
Kidney Foundation of Peru (KFP), Peru 2005/2007
Kidney Foundation of Samoa (KFS), Samoa 2007
National Kidney Foundation (NKF), Singapore 2005
National Kidney Foundation (NKF), South Africa 2005/2007
The Nierstichting/Dutch Kidney Foundation (DKF), The Netherlands
2005/2007
Turkish Kidney Foundation (TKF), Turkey 2005/2007
Anatolia Kidney Foundation (AKF), Turkey 2005/2007
Kidney Wales Foundation (KWF), United Kingdom (UK) 2007
Kidney Research UK (KRUK), UK 2005/2007
National Kidney Federation (NKF), UK 2005/2007
National Kidney Foundation (NKF), United States of America (USA)
2005/2007
National Kidney Foundation of Northeast New York (NKFNENY), USA 2005
Northwest Kidney Center (NWKC), USA 2007
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Pakistan. There are screening programs for high-risk
groups in rural and urban populations.
Peru. The newly formed NGO ‘Rurum Wasi’ has
commenced a health education program in the rural
highlands (Chacas and Huaraz).
Samoa. Kidney Foundation of Samoa launched a na-
tional population-based screening program, for early detec-
tion of noncommunicable chronic diseases.
Singapore. NKF Singapore has well-established programs
of population-based health screening at the primary care level
and of primary and secondary prevention.
South Africa. The Chronic Disease Outreach Primary
Prevention Program at the Dumisane Mzamane African
Institute of Kidney Disease has a pilot program in high-risk
groups in 20 clinics in Soweto. Progress includes increased
awareness and improved management of CKD by nurses,
integration of chronic diseases more broadly, database
training, and an Internet database. A new local population-
based screening program is also beginning.
The Netherlands. DKF commenced its nationwide Nierch-
eck campaign (Kidney Check: testing for proteinuria) in
2006. The University Hospital of Groningen’s prevention of
renal and vascular endstage disease (PREVEND) research
program (1997) has conducted community-based screening.
There is some evaluation of high-risk groups in general
practice. Screening guidelines are being developed for general
practitioners and non-nephrological specialists. An educa-
tional program for nurse practitioners and district nurses is
about to start. An e-learning program is planned.
Turkey. The Chronic Renal Disease in Turkey Study was
started in 2007. This includes screening for prevalence of
CKD, hypertension and other kidney diseases in five different
regions of Turkey (conducted through the Turkish Society of
Nephrology (TSN) and the Turkish Kidney Foundation), and
there had been 16,380 participants at time of reporting. TSN
and the Universities were soon to commence a screening and
follow-up program. Educational programs for health profes-
sionals and the general public were increasing (Anatolia
Kidney Foundation, Turkish Kidney Foundation). A local
pilot screening study was planned in Ufuk (Anatolia Kidney
Foundation and Ufuk University). Merging of the social
security systems has improved the availability of drugs,
treatments, and services.
United Kingdom. A legislated National Service Framework
for renal services is being established. The requirement for
e-GFR testing at primary care level for at-risk patients started
in 2007. A KEEP style program was expected to run as a pilot
by late 2007. Identification of CKD has improved. Kidney
Wales Foundation was to launch a pilot electronic care
pathway for CKD detection and management in early 2008.
United States of America. The US NKF has had KEEP for
several years, which screens high-risk groups in the commu-
nity, at multiple sites, nationwide. It has also developed
education materials for primary care providers, clinical
practice tools, and public and patient education packages.
It is developing a new program for the public-at-large—
Kidney Health Risk Assessment—which identifies CKD risk
factors: at-risk individuals are provided educational materials
and invited to the next free local KEEP screening. Finally, the
NKF conducts and supports advocacy and government
relations. The National Institute of Health’s National Kidney
Disease Education Program continues to evolve. It includes
educational components for populations at high risk of CKD
and a family reunion outreach program, and is now focused
on standardization of serum creatinine measurement for use
in e-GFR calculations. The Centers for Disease Control and
Prevention designated CKD as a major public health issue in
2006, and has begun to develop a chronic kidney disease
screening program, through collaboration with the NKF.
Target groups and settings
Most respondents designated high-risk groups as priorities for
screening, such as people with diabetes, cardiovascular disease,
hypertension, lipid disorders, obesity, older adults (440 years
in Singapore, older elsewhere), smokers, patients with kidney
stone history, people with a family history of kidney disease,
and high-risk ethnic or minority groups (Indigenous Peoples,
Asian, South Asian, Pacific Islanders, African, Caribbean, and
Hispanic origin were specifically cited). School children and
youths were also specifically targeted (Argentina, India, Italy,
Nigeria, Pakistan, Samoa, Singapore, The Netherlands, Turkey),
and in Turkey, especially children with urinary incontinence or
abnormal urine color.
There were several models of screening, often more than
one existed within an organization or region. Community-
wide screening was specified by some respondents (Australia,
Bangladesh, Canada, India, Italy, Pakistan, Samoa, Singapore),
targeting whole towns and villages, the general public or
disadvantaged areas. Some described opportunistic screening
(Moldova, Singapore, Turkey), and some conducted workplace
screening through corporations, (Australia (pending), Canada,
India, Japan, Samoa, Singapore). Pilot studies of community-
based prevalence were underway in several target regions in
Turkey, and rural house-to-house screening was being carried
out in some areas of India and Pakistan.
Health care groups and providers especially targeted for
education were: general practitioners, physicians, diabetolo-
gists, nurses, healthworkers and dietitians (Argentina,
Australia, Bangladesh, India, Ireland, Italy, Mexico, Pakistan,
Singapore, The Netherlands, USA), whereas legislators and
social and economic policy makers were current or intended
targets for education, lobbying and legislative changes.
The physical settings for screening were likewise various.
Some were based on hospital outpatients and diabetic clinics
(Czech Republic, Fiji, Mexico). Some included primary care
or family practice/general practitioner settings (Australia,
India, Ireland, Mexico, Moldova, South Africa, The Nether-
lands) and community health centers in townships and
villages (Australia, Bangladesh, India, Pakistan). Commu-
nity-based screening was conducted at health fairs, commu-
nity pharmacies, corporate offices, churches, factories and
shopping malls (Canada, India, Japan, Singapore). Some
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programs used mobile clinics (Italy), or screened village-wide
or house-to-house, whereas others had organized screening
camps for high-risk groups (Tamilnadu Kidney Research,
India). Children were often screened in schools (Japan,
Singapore, Turkey).
Screening tests
Table 2 shows the elements of testing reported. The majority
of programs (74%) included weight, height, blood pressure, a
measure of blood glucose and a urine dipstick, and most
routinely induced a serum creatinine measurement (63%).
Some tested lipids and albumin-to-creatinine ratio (ACR) or
protein-to-creatinine ratio (PCR) routinely, whereas others
included those tests and serum creatinine only if other
conditions were met. At least seven organizations also did
liver function tests, at least ‘if required’.
Data management
Data management was electronic in most major programs, or
was planned (Wales). Fiji and Peru were hoping for computer
systems to be implemented and Malaysia had a paper-based
system.
Frequently cited needs
K Recognition of CKD by governments as a health priority
area.
Table 2 | Screening tests performed
Tests as required
Responding organization,
or program, year Weight Height Waist BP
Urine
dipstick
Blood
glucosea
Serum
creatinine Hemoglobinb HbA1c Lipids
Urine
ACR/PCR
Argentina, ASIR 2007 + + + + + + + +
Australia, KHA 2007
Australia, ACDOP 2005 + + + + + +/a + + + + +
Bangladesh, KF 2007 + + + + +a + +
Bulgaria, BRA 2007 + + + + + +a + + + +
Canada, KFC 2005 + +
Czech Rep, CKF 2007 + + + + +a + + + +
Egypt, NKF 2005
Fiji, KFF 2005
India, NKFI 2005 + + + + + + +
India, TANKER 2007 + + + + + +
India, INKF 2007 + + + + + +a + +b + + +
Iran, PKFI 2007
Ireland, IKA 2005 + + +
Italy, FIR 2007 + + + + +
Italy, RCF 2007 + + + + +a + +b + +
Japan, IKEAJ 2007 + + + + + +a + +b + + +
Malaysia, KFM 2005 +
Mexico, FMR 2005 + + +
Moldova, KFM 2007 + + + + +a + +b + +
New Zealand, NZKF 2007 + + + + +a + +b + + +
Nigeria, KWI 2005
Nigeria, KCI 2007
Pakistan, KFP 2007 + + + + + +a + +b + +
Peru, KFP 2005
Samoa, KFS 2007 + + + + + +a + +b + + +
Singapore, NKF 2005 + + + + + + +
South Africa, Soweto 2007 + + + + + +a + +b + + +
The Netherlands, PREVEND, 2005 + + + + +a +
Turkey, TKF 2007 + + +
Turkey, AKF 2007 + + + +
UK, KWF 2007
UK, KRUK 2005
UK, NKF 2007
USA, NKFNENY 2005 + + + + + + + +
USA, NKF 2005 + + + + + + + +
USA, NWKC 2007 + + + + +a + + +
ASIR, Asociacion Solidaria de Insuficientes Renales; KHA, Kidney Health Australia; ACDOP, Aboriginal Chronic Disease Outreach Program; KF, Kidney Foundation; BRA, Bulgaria
Renal Association; KFC, Kidney Foundation of Canada; CKF, Czech Kidney Foundation; NKFE, National Kidney Foundation Egypt; KFF, Kidney Foundation of Fiji; NKFI, National
Kidney Foundation India; TANKER, Tamilnadu Kidney Research; INKF, Institute of Nova Kidney Foundation; PKFI, Patient’s Kidney Foundation of Iran; IKA, Irish Kidney
Association; FIR, Fondazione Italiana del Rene; RCF, Renal Child Foundation; IKEAJ, International Kidney Evaluation Association Japan; KFM, Kidney Foundation Malaysia; FMR,
Fundacion Mexicana del Rinon; KFM, Kidney Foundation of Moldova; NZKF, New Zealand Kidney Foundation; KWI, Kidney Watch Initiative; KCI, Kidney Consultants
International; KFP, Kidney Foundation of Pakistan; KFP, Kidney Foundation of Peru; KFS, Kidney Foundation of Samoa; NKF, National Kidney Foundation; DKF, Dutch Kidney
Foundation; TKF, Turkish Kidney Foundation; AKF, Anatolia Kidney Foundation; KWF, Kidney Wales Foundation; KRUK, Kidney Research UK; NKFNENY, National Kidney
Foundation of Northeast New York; NWKC, Northwest Kidney Center.
aFasting blood glucose level performed as well as random blood glucose level.
bFull blood count also performed.
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K Assistance with program design, including program
structure and administration.
K Information from the experience of other programs,
invited speakers and exchange programs; educational and
promotional materials; information and opportunities for
training, development of clinical skills, and assistance with
technology and information management and transfer.
K Assistance with database development, data analysis and
data reporting in several countries that were generating
data (Argentina, Czech Republic, New Zealand, Nigeria,
Pakistan, Samoa, National Kidney Foundation India,
Tamilnadu Kidney Research, India (reporting only),
Malaysia, South Africa). Some organizations had ade-
quate capabilities and resources (Bangladesh, Bulgaria,
Iran, Italy, Mexico, Moldova, The Netherlands, Turkey,
UK, USA).
K Funding and resources (any or more) in most settings,
with the notable exception of Singapore, where programs
were adequately resourced.
K Collaborative influence and clout from the IFKF and other
bodies for advocacy with local authorities, both in countries
with existing programs and those who wanted them.
K A more active role of the IFKF website as a repository of
information, for referral, to expose current successes, and
in promoting World Kidney Day (WKD). It was also
suggested that the IFKF host more international meet-
ings, help strengthen and expand partnerships with other
organizations, corporations and government agencies,
and facilitate links with big international organizations
like the World Health Organization. Finally, it was
suggested that IFKF link up with other CKD and chronic
disease efforts on a global basis.
Impact of World Kidney Day
At the IFKF meeting in Dublin 2005, it was resolved to
support the ISN’s initiative of WKD, rather than create a
separate platform for raising consciousness. Incidentally,
Dr Joel Kopple, who founded the IKFK, was also the prime
instigator of WKD. Respondents in 2007 were very positive
about the impact of WKD, although some needed more time
to assess. Respondents cited WKD’s ability to rally awareness
of the media, families, the general public, health care
generalists and specialists, entire countries and the global
community. It improved knowledge of the prevalence and
risk factors for CKD, the need for early detection, and its
potential for modification by good management. It prompted
educational opportunities (Argentina, Australia, Canada,
Czech Republic, National Kidney Foundation India, Tamil-
nadu Kidney Research, India, Italy, Nigeria, Peru, Turkey,
UK, USA), targeted activities like walkathons, health fairs,
exhibitions, art competitions, screening activities, national
conferences and award ceremonies. It provided the occasion
for petitions, delegations and presentations to government
(India Institute of Nova Kidney Foundation, Malaysia, South
Africa, USA National Kidney Foundation of Northeast New
York, USA Northwest Kidney Center) and for the official
launch of the National Service Framework for renal disease in
the UK and several other UK CKD programs. WKD
coincided with the initiation of Niercheck in the Netherlands.
It was suggested (by Italy) that the IFKF’s website give more
exposure to WKD and to the related activities and successes
in responding organizations.
Progress 2005–2007
Organizations in Australia, Canada, India, Malaysia, Mexico,
Nigeria, Peru, South Africa, The Netherlands, Turkey, United
Kingdom and USA provided follow-up data. All reported
some progress. Most cited growth in CKD awareness and
improved management and program planning, and many
cited additional education and prevention programs. Among
them, only Nigeria and Peru still had no existing or
imminent screening programs.
CONCLUSION
There are many limitations in this report. First, half the
organizations did not respond. Lack of personnel, organiza-
tional stability, funding, morale and e-mail access undoubt-
edly contributed, so that the survey is heavily weighted in
favor of organizations with something positive to report.
Second, the questionnaires were not designed as research
tools, most questions were open ended, answers were
supplied in free form and the baseline and follow-up
questionnaires were not worded in precisely the same way.
Third, the necessary paraphrasing, grouping, and compres-
sion of answers limit accuracy and potential for discernment.
Fourth, the answers are already outdated for all respondents,
even those who replied in 2007, and they are seriously
outdated for those whose most recent response was in 2005.
Nonetheless, the report shows considerable activity in
CKD detection and prevention activities in some of the
regions that the IFKF membership represents. The larger
organizations and those in affluent countries with stable
governments report progress. The best prospects for strong
and sustained programs are likely to be those that can be
embedded in national health care policy and practice.
However, the productivity of KEEP in the USA shows what
affluence and the support of major academic/scientific
organizations can achieve.
Smaller organizations or those in resource-poor regions
are struggling and some have not been able to develop
programs at all. Some felt discouraged and isolated, and
uncertain about available assistance and how to access it.
These especially, and other programs to various degrees, need
robust and committed support. The current models of
assistance, which include visiting speakers, small short-term
grants, exchange scholarships and gratis help from other
organizations, need to be supplemented by strong and
sustained help and funding mechanisms. Each country or
region should be supported in conducting limited prevalence
studies of disease and risk factors, and then in persuading
governments to support policies of prevention, early
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detection, and treatment. The argument would be based on
humane grounds, as well as on cost effectiveness, estimates of
which should factor in delay of disability and death in the
most economically productive members of society. Major
grants for multinational programs should be pursued, with
potential sponsors identified like the Bill Gates Foundation,
the Wellcome Trust, World Health Organization, and the
World Bank. Such agencies would be more attracted if
initiatives were linked to chronic disease more broadly; a
concept, which the broad menu of tests for CKD, proffered
by the respondents in this study, already accommodates.
METHODS
In early 2005 questionnaires were sent by e-mail and post to IFKF
members, using the executive’s contact list. A compilation of replies
was presented at the Dublin IFKF meeting in May 2005, and sent out
by e-mail in September 2005. In 2007, organizations that responded
in 2005 were sent a follow-up questionnaire, whereas the 13 new
members of IFKF, and those who had not previously responded,
were sent the original questionnaire.
The nature of, or opportunities for, ‘prevention’ programs,
regionally or nationally, were queried, together with the setting of
such activities, groups targeted for screening and education,
screening tests performed and data management methods and
requirements. They were also asked for their impression of program
prospects, challenges and obstacles, and the extent of government
and nongovernment support or collaborations. These question-
naires are shown in the appendix.
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APPENDIX: DATA COLLECTION INSTRUMENTS
1. IFKF 2005 Initial CKD Questionnaire
IFKF 2005 Initial CKD QUESTIONNAIRE
Name:
Country or Area being represented:
Address:
Phone:
Email:
1. What is actually happening with prevention and
detection?
2. What would you like to see happening?
3. What are the target education and screening groups?
4. In what settings would you test?
5. What do (or would you) test for?
6. What would you test with?
7. How would you follow the data and outcomes?
8. What information systems do you have?
9. What are the prospects for the programs spreading further?
10. What are the prospects for sustainability?
11. In what ways do you work with other organisations, in
public health, primary care, diabetes, cardiovascular
disease, hypertension, lung associations, etc?
12. What are your links to government and other powerful
groups?
13. What is the level of your country’s commitment?
14. What are your unmet needs?
15. How could you be helped?
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